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Carbonic anhydrase isozyme CA3 protects cells against oxidative stress. Ec-
topic expression of murine Ca3, but not Ca2, protects proto-oncogene Evi1 
expressing Rat1 fibroblast cells (ca3low) against hydrogen peroxide (H2O2) 
induced stress. Ca3 is S-glutathionylated via glutathione adducts with cyste-
ines 181 and 186. Substitution of both Ca3 cysteines with serine fails to pro-
tect cells from oxidative stress. Insertion of cysteine at 181 and 186 in Ca2 is 
insufficient for conferring efficient anti-oxidant activity. This shows for the 
first time that S-glutathionylation of cys181 and cys186 residues is required 
for Ca3 anti-oxidant activity but that additional factors are also required. 
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Intracellular pH is partly regulated by a family of carbonic anhydrase (CA, 
EC4.2.1.1) enzymes that reversibly catalyse the hydration of carbon dioxide to 
bicarbonate and hydrogen ions [1]. The α-CAs comprise 15 distinct zinc metal-
loenzymes that can be sub-divided into cytoplasmic (CAI, CAII, CAIII, CAVII, 
CAXIII), membrane bound (CAIV, CAIX, CAXII, CAXIV, CAXV), mitochon-
drial (CAV), non-catalytic (CAVIII, CAX, CAXI) and secreted (CAVI) [2]. 
These ubiquitous enzymes are of significant importance for many physiological 
processes and are implicated in various pathological conditions including athe-
rosclerosis [3], retinitis pigmentosa [4], myasthenia gravis [5] and cancer [6]. 
Carbonic anhydrase III (CA3) is unique in this family as it has low hydratase 
activity [7] but it is very abundant in liver, skeletal muscle and adipose tissue. 
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However, surprisingly for such an abundant protein (e.g. 2% of wet weight in 
slow oxidative muscle (type 1) [8]) its function remains an enigma. Until re-
cently Ca3KO mice were believed to lack any functional deficit [9] but have now 
been shown to display impaired mitochondrial ATP synthesis [10]. In addition, 
these mice show changes in expression of genes involved in oxidative stress [11]. 
This implies CA3 might participate in the cellular response to oxidative stress. 
There is mounting evidence that strongly suggests CA3 is an anti-oxidant. 
Tissue in which it is abundant is those whose metabolic activity results in consi-
derable oxidative stress, including aerobic respiration in skeletal muscle and li-
pid metabolism in adipose tissue. CA3 expression is co-induced with established 
anti-oxidant genes such as superoxide dismutase following endurance training 
in elite athletes when skeletal muscle is exposed to increased oxidative stress [12] 
[13].  
Functional molecular evidence, in addition to the associated expression stu-
dies above, shows that CA3 has anti-oxidant activity. Enforced CA3 expression 
in NIH3T3 cells protects them from hydrogen peroxide (H2O2)-induced apopto-
sis [14]. EVI1 proto-oncoprotein transformed Rat1 fibroblasts have repressed 
ca3 expression and either transgene mediated restoration of Ca3 in these cells or 
direct RNAi mediated Ca3 KD in parental Rat1 cells (high endogenous ca3) 
protects and sensitizes cells to H2O2 induced apoptosis respectively [15]. Insight 
into a possible mechanism of CA3 anti-oxidant activity has been obtained from 
post-translational modification observed in cells during oxidative stress. CA3 is 
modified by S-glutathionylation in response to t-butylhydroperoxide or mena-
dione in cultured hepatocytes [16] as well as in stressed skeletal muscle [11]. 
Crystal structure studies and site directed mutagenesis reveal two cysteine re-
sidues, cys181 and cys186, are available for the addition of glutathione adducts 
via transient formation of oxidised cysteine sulfenic acid intermediates [17] 
[18].  
S-glutathionylation of CA3 is believed to help protect and aid recovery of cells 
from the damaging effects of oxidative agents. Previous studies showing that 
CA3 has anti-oxidant activity and that the protein is S-glutathionylated has led 
to speculation that the two processes are connected [18]. Direct functional evi-
dence for this is lacking. In this study advantage is taken of our previous analysis 
in Rat1 fibroblast cells [15]. Derivative Evi1 proto-oncoprotein expressing Rat1 
fibroblast cells, designated 5.61, have low ca3 and increased sensitivity to oxida-
tive stress but become resistant upon restoration of ca3 levels by ectopic expres-
sion of Ca3. 5.61 cells are used here to explore the relationship between CA3 
S-glutathionylation and CA3 anti-oxidant activity.   
2. Materials & Methods 
Cell Culture 
Rat1 fibroblast cells and Evi1 expressing Rat1 cell population 5.61 cells have 
been described previously [15]. Rat1 and 5.61 cells were cultured in complete 
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medium (CM) comprising Dulbecco’s Modified Eagle’s Medium (Lonza Group 
Ltd, Basel, Switzerland, BE12-604F) supplemented with 5% newborn calf serum 
(Sigma-Aldrich, Poole, UK, N4637) and 2.5 mM glutamine, 50 μg/ml penicillin, 
50 units/ml streptomycin (Lonza Group Ltd., BE17-605E & BE17-603E), 500 
μg/ml G418 (5.61 cells only, Invitrogen, Paisley, UK), 37˚C, 5% CO2. For hydro-
gen peroxide (H2O2) treatment, cells were incubated in CM supplemented with 
750 mM H2O2 (Sigma-Aldrich, 21676) for 16 hrs. 
Preparation of Plasmid DNA 
Plasmids pCMVsport6Ca3 (I.M.A.G.E. Id 4195712), pCMVsport6Ca2 (I.M.A.G.E. 
Id 6479187) and pRLCMV have all been described previously (Source Bios-
cience, geneservice, Cambridge, UK; Stratagene, La Jolla, CA, USA). Plasmid 
DNA’s were prepared by affinity chromatography using Nucleobond® PC500EF 
gravity flow columns according to manufacturer’s instruction (Macherey-Nagal 
GmbH & Co. Kg, Düren, Germany). 
Site Directed Mutagenesis 
Point mutations of Ca2 and Ca3 gene sequences were created by Quick 
ChangeTM XL site directed mutagenesis using either pCMVsport6Ca2 or 
pCMVsport6Ca3 DNA, according to the manufacturer’s instructions (Agilent 
technologies, USA). Briefly, 50 ng of plasmid DNA was mixed with 125 ng for-
ward and reverse primers, 1 μl dNTP’s, Pfu Turbo DNA polymerase (2.5 U) in 
50 μl and incubated 95˚C, 30 sec then 14 cycles of 95˚C 30 sec, 55˚C 1 min fol-
lowed by 68˚C 6 min in a programmable thermocycler (MJ Scientific, Hampton, 
New Hampshire, USA, PTC-100). N186C (Ca2) and C181S (Ca3) mutant plas-
mid DNA’s were used as template for site directed mutagenesis to create double 
mutants S181CN186C (Ca2) and C181SC186S (Ca3) respectively. Oligonucleo-
tide primers for site directed mutagenesis were designed using the site directed 
mutagenesis primer design tool (Agilent technologies) and synthesized by Inte-
grated DNA Technologies (BVBA, Leuven, Belgium). Ca2 S181C FP:  
GCTAACTTTGATCCTTGCTGCCTTCTTCCTGGAAAC; Ca2 S181C RP:  
GTTTCCAGGAAGAAGGCAGCAAGGATCAAAGTTAGC; Ca2 N186C FP:  
TTGCTCCCTTCTTCCTGGATGCTTGGACTACTGGACATAT; Ca2 N186C  
RP: ATATGTCCAGTAGTCCAAGCATCCAGGAAGAAGGGAGCAA;  
Ca2 S181CN186C FP:  
GATCCTTGCTGCCTTCTTCCTGGATGCTTGGACTAC; Ca2 S181CN186C  
RP: GTAGTCCAAGCATCCAGGAAGAAGGCAGCAAGGA 
TC; Ca3 C181S FP: TTTTACACACTTTGACCCATCAAGCC 
TGTTCCCTGCTTGCCG; Ca3 C181S RP:  
CGGCAAGCAGGGAACAGGCTTGA 
TGGGTCAAAGTGTGTAAAA; Ca3 C186S FP:  
CATGCCTGTTCCCTGCTAGCC 
GGGACT; Ca3 C186S RP: AGTCCCGGCTAGCAGGGAACAGGCATG;  
Ca3 C181SC186S FP:  
CAAGCCTGTTCCCTGCTAGCCGGGACTATTGGACCT 
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ACC; Ca3 C181SC186S RP:  
GGTAGGTCCAATAGTCCCGGCTAGCAGGGAACAGGCTTG.  
Sequencing 
Point mutation of Ca2 and Ca3 gene sequences were verified by partial se-
quencing of plasmid DNA (DNA Analysis Facility, Human Genetics Unit, Ni-
newells Hospital, Dundee, UK). DNA sequence analysis was performed using 
FinchTV version 1.4.0. 
DNA Mediated Transfection 
5.61 cells were transfected with 1 μg plasmid DNA using Fugene6® (Roche 
Diagnostics GmbH, Mannheim, Germany, 11815091001). 1 × 105 cells were in-
cubated with a 1:6 ratio DNA: FuGENE6®, prepared as described by the manu-
facturer, for 48 hrs.  
Caspase 3 Assay 
Cells were incubated in 96 well dishes (Costar 3917) and apoptosis deter-
mined by the Caspase 3/7-Glo® assay according to the manufacturer’s instruc-
tions (Promega, G8090), measuring luminescence with a Fluostar OPTIMA lu-
minometer (BMG LABTECH). 
Western Blot Analysis 
Protein extracts, SDS polyacrylamide gel electrophoresis and western blotting 
were performed as described previously [15] with either α-ca3 (Santa Cruz Bio-
technology Inc., Santa Cruz, CA, USA, E-19), α-ca2 (Santa Cruz Biotechnology 
Inc, Santa Cruz, CA, USA, C-10) or α-gapdh (Fitzgerald Industries, North Ac-
ton, MA, USA, 6C5) and diluted 1/1000 (E-19), 1/200 (C-10) or 1/5000 (6C5). 
Appropriate HRP conjugated α-goat (Sigma-Aldrich, A5420) or α-mouse (Sig-
ma-Aldrich, A9044) IgG secondary antibodies were used at 1/5000 dilutions and 
detection was performed by enhanced chemiluminescence (Pierce, Rockford, IL, 
USA, 32209). 
Statistical Analysis 
Statistical significance was determined by two-way ANOVA using GraphPad 
PRISM® 7.0c software. P ≤ 0.05 was considered significant. 
3. Results 
Ca3 but not Ca2 protects cells from oxidative stress 
Murine Ca2 and Ca3 proteins show 60% amino acid identity (Figure 1). In-
itially we examined and compared the anti-oxidant activity of these two proteins 
in cells. Evi1 transformed Rat1 cells (5.61) were chosen for this purpose as they 
have previously been shown to express low levels of ca3 [15] and they are −ve for 
ca2. Both genes were transiently expressed for 48 hrs in 5.61 cells using 
pCMVsport6Ca2 and pCMVsport6Ca3 expression vectors as described in mate-
rials and methods. Western blot analysis with α-ca3 (Santa Cruz E-19) antibo-
dies shows elevated levels of Ca3 in pCMVsport6Ca3 transfected 5.61 cells rela-
tive to parental (UT) or empty vector (pRCCMV) transfected cells (Figure 2(a)). 
Similarly, western blot analysis with α-ca2 (Santa Cruz D-8) shows abundant  
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Figure 1. Comparison of the primary amino acid sequence of murine Ca2 (Accession 
number NM_009801) and Ca3 (Accession number NM_007606) proteins. Identity of 
amino acid sequences are indicated using the single letter code. Regions of Ca2 identical 
with Ca3 are indicated by −. Cysteine residues 181 and 186, present in Ca3 but absent 
from Ca2 are highlighted by a boxed C in bold. 
 
 
Figure 2. Caspase 3 activity in H2O2 treated 5.61 cells with enforced expression of Ca2 
and Ca3. (a) and (b) show representative examples of western blot analysis of whole cell 
extracts derived from untransfected (UT) 5.61 cells or 5.61 cells transfected with empty 
vector (pRC CMV), Ca2 (Ca2wt) or Ca3 (Ca3wt) expression vectors for 48 hrs with α-ca2 
(C-10), α-ca3 (E-19) and α-gapdh (6C5) antibodies. The expected 29 kDa Ca2, 27 kDa 
Ca3 and 35 kDa gapdh proteins are indicated; (c) shows a histogram of relative caspase 3 
catalytic activity in untransfected (UT), empty vector (pRC CMV) transfected and Ca2 
(Ca2wt) or Ca3 (Ca3wt) overexpressing 5.61 cells + (white columns) or − (black col-
umns) 16 hrs H2O2. Histogram is the mean value of three measurements and the error 
bars the SEM. Statistical analysis shows two-way ANOVA and Dunnetts multiple com-
parisons test of H2O2 treated pRC CMV vs UT or Ca3wt or Ca2wt, *P < 0.05, ***P < 
0.001, ****P < 0.0001. 
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Ca2 protein in pCMVsport6Ca2 transfected 5.61 cells which is absent from pa-
rental (UT) and empty vector (pRCCMV) transfected cells (Figure 2(b)). In 
each case, western blot analysis with α-gapdh (Santa Cruz 6C5) confirmed even 
loading of proteins. 
Next, we investigated the anti-oxidant activity of Ca2 and Ca3 in 5.61 cells. 
Cells were transiently transfected with Ca2 or Ca3 expression vectors as de-
scribed above and then treated with 750 μM H2O2 for 16 hrs. H2O2 induced 
apoptosis was examined by measuring caspase 3 catalytic activity as described in 
materials and methods. Ca2, Ca3 or empty vector control cells all show low cas-
pase 3 catalytic activity in the absence of H2O2 treatment (Figure 2(c)). Caspase 
3 catalytic activity is induced in each case following H2O2 treatment but is sig-
nificantly less in Ca3 expressing cells (Figure 2(c), pRC CMV vs Ca3wt, ****P < 
0.0001). In contrast, Ca2 expression does not protect 5.61 cells from H2O2 in-
duced apoptosis (Figure 2(c), Ca2wt). These data confirm that Ca3 protects cells 
from oxidative stress induced apoptosis and that this property is not shared by 
the Ca2 isozyme. 
Cysteines 181 and 186 are necessary for Ca3 anti-oxidant activity in Rat1 
cells 
Reversible oxidative stress induced ca3 S-glutathionylation occurs on cysteine 
residues 181 and 186 [18]. A full length wild type (wt) Ca3genecDNA in 
pCMVsport 6 was mutated by site directed mutagenesis (materials & methods) to 
encode Ca3serine at position 181 (Ca3C181S), Ca3serine at position 186 (Ca3C186S) 
single mutant or Ca3 serine at position 181 and 186 (Ca3C181SC186S) double mu-
tant proteins, that have previously been shown to inhibit S-glutathionylation 
[18]. To confirm their expression, the wt and mutant Ca3 proteins were each 
transiently over-expressed by transfection of the various constructs in 5.61 cells. 
Western blot analysis of whole cell extracts derived from the transfected cells 
with α-ca3 shows over-expression of wt and mutant 27 KDa Ca3 proteins in 
transfected cells (Figure 3(a)) relative to the endogenous protein in empty vec-
tor transfected 5.61 cells (Figure 3(a), pRCCMV). In each case, western blot 
analysis with α-gapdh confirmed even loading of proteins. 
The mutant Ca3 proteins were next examined for anti-oxidant activity. 5.61 
cells transiently transfected with constructs encoding either wt or mutant Ca3 
proteins were examined for caspase 3 catalytic activity (materials and methods) 
either with or without 750 μM H2O2 treatment for 16 hrs. The results show low 
caspase 3 enzyme catalytic activity is significantly induced following exposure to 
H2O2 in each case (Figure 3(b)). As before, there is a highly significant reduction 
in caspase 3 enzyme catalytic activity in cells with enforced expression of wt Ca3 
(Figure 3(b) pRC CMV vs Ca3wt, ****P < 0.0001) confirming anti-oxidant ac-
tivity. However, the H2O2 induced caspase 3 enzyme catalytic activity is induced 
to either a greater (Figure 3(b) pRC CMV vs UT ****P < 0.0001 or Ca3C181S 
**P < 0.01 or Ca3C186S **P < 0.01) or similar extent (Figure 3(b) pRC CMV vs 
Ca3C181SC186S) in all other cells that are either untransfected (UT) or  
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Figure 3. Caspase 3 activity in H2O2 treated 5.61 cells with enforced expression of Ca3 
and Ca2 encoding wt, cysteine 181 and 186 mutant proteins. (a) shows western blot anal-
ysis of whole cell extracts derived from transfected 5.61cells with the empty vector control 
pRC CMV or over expressing the indicated Ca3wt and mutant proteins. The antibodies 
used and the Ca3 and gapdh proteins detected are as indicated in figure legend 2; (b) 
shows a histogram of relative caspase 3 catalytic activity in untransfected (UT), empty 
vector (pRC CMV), Ca3wt, indicated Ca3 cysteine mutant, Ca2wt and indicated Ca2 se-
rine or asparagine mutant overexpressing 5.61 cells + (white columns) or − (black col-
umns) 16 hrs H2O2. Histogram is the mean value of three measurements and the error 
bars the SEM. Statistical analysis shows two-way ANOVA and Dunnetts multiple com-
parisons test of H2O2 treated pRC CMV vs UT or Ca3wt or C181S or C186S or 
C181SC186S or Ca2wt or Ca2S181C or Ca2N186C or Ca2S181CN186C, **P < 0.01, ***P 
< 0.001, ****P < 0.0001. 
 
transfected with one of the three Ca3 mutant proteins. This shows mutant 
Ca3proteins are no longer protective in Rat1 cells exposed to oxidative stress. 
Cysteines 181 and 186 are insufficient to confer anti-oxidant activity on 
Ca2 in Rat1 cells 
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The Ca2 amino acids serine 181 (Ca2S181C) and asparagine 186 (Ca2N186C) were 
converted to cysteine residues, by site directed mutagenesis of pCMVsport6Ca2 
expression vector DNA, to see if this would confer anti-oxidant activity on the 
Ca2 protein. Ca2wt, Ca2S181C, Ca2N186C single mutant and Ca2S181CN186C 
double mutants were each transiently expressed in 5.61 cells (materials and me-
thods). Western blot analysis of cell extracts with α-ca2 shows the presence of 
similar amounts of the expected wt and mutant 29KDa proteins in transiently 
transfected cells which is absent from cells transfected with the empty vector 
control (Figure 3(c)). In each case, western blot analysis with α-gapdh con-
firmed even loading of proteins (Figure 3(c)). The mutant Ca2 proteins were 
examined for antioxidant activity in H2O2treated cells as before. No significant 
difference was observed in H2O2 induced caspase 3 catalytic activity when com-
pared to empty vector control (pRC CMV) cells (Figure 3(b)) but there was a 
minor but significant reduction with the double mutant protein (Figure 3(b) 
pRC CMV vs Ca2S181CN186C ***P < 0.001). 
4. Discussion 
It is now widely accepted that CA3 undergoes S-glutathionylation [19] and that 
this post-translational modification is elevated by either chemical [16] [20], in-
cluding H2O2 [21] or exercise [11] mediated oxidative stress in cultured cells and 
intact tissues in various mammalian species examined. X-ray crystallography 
shows that both rat ca3 and S-glutathionylated ca3 are structurally very similar 
and that two surface exposed cysteine residues (C181 and C186) participate in 
adduct formation [17]. Substitution of both C181 and C186 for serine complete-
ly abolishes S-glutathionylation of Ca3 [18]. We show in this study that Ca3 
C181 and C186 are both essential for in vivo Ca3 anti-oxidant activity and that 
S-glutathionylation is therefore an essential feature of the mechanism by which 
this protein participates in protecting cells from oxidative stress.  
Mutation of either C181, C186 or both to serine residues are equally effective 
at inhibition of Ca3 anti-oxidant activity. Previous studies show that C186 is 
preferentially S-glutathionylated relative to C181, suggesting that this residue 
might be more important in anti-oxidant activity [18]. However, the same stu-
dies also show that the efficiency of C186 S-glutathionylation is significantly re-
duced in the C181 mutant Ca3 protein (70% reduction). These observations are 
consistent with our results that mutation of either one or both of these cysteine 
residues to encode a serine has a significant impact on Ca3 biological activity as 
an anti-oxidant. 
Our results also confirm previous studies [14] that the closely related Ca3 
protein, Ca2, does not share anti-oxidant activity. Furthermore, we show that 
the introduction of cysteines at positions 181 and 186 of the Ca2 protein is in-
sufficient to confer anti-oxidant activity although there is a minor increase in the 
presence of both residues. This result suggests other factors, which might impact 
on the efficiency of S-glutathionylation, are required for anti-oxidant activity. 
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The S-glutathionylated cysteine residues in Ca3 have a low pKa [18] and 
S-glutathionylation is affected positively and negatively by lysine 211 and glu-
tamic acid 188/aspartic acid 212 respectively. The pKa of the cysteine residues in 
mutant Ca2 have not been determined, however the lysine, aspartic acid and 
glutamic acid amino acids are conserved in Ca2. The S-glutathionylation process 
can occur spontaneously (reviewed in [22]) but can be catalysed. Gluta-
thione-S-Transferase π (GSTP) catalyses S-glutathionylation of both 1-CYS pe-
roxiredoxin [23] and cardiac aldose reductase [24]. Homozygous KO mice dep-
leted of GSTP show a general reduction in oxidative stress induced protein 
S-glutathionylation [25] suggesting this protein might be involved in conjuga-
tion of glutathione to other proteins, including Ca3. Therefore, there might be 
other molecular determinants of Ca3 S-glutathionylation besides C181 and C186 
that are absent from Ca2. 
The CA3 C181 and C186 residues are conserved in all mammalian species 
examined, including human, rat, murine and bovine, but only C181 is found in 
xenopus and neither residues are observed in chicken or zebrafish (data not 
shown). This suggests that only mammalian CA3 has evolved anti-oxidant activ-
ity, but this would need to be tested experimentally as other cysteine residues 
might be S-glutathionylated in non-mammalian species. For example, the CA3 
isozyme CAVII is also S-glutathionylated but at cysteine residues C183 and C217 
[26]. 
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